REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 5th, 2024 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 5, 2024, between Adverum Biotechnologies, Inc., a Delaware corporation (the “Company”), and each of the several investors signatory hereto (each, an “Investor” and, collectively, the “Investors”).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT ADVERUM BIOTECHNOLOGIES, INC.Security Agreement • February 5th, 2024 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
This Warrant is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated February 5, 2024, by and among the Company and the Purchasers identified therein (the “Purchase Agreement”). All such warrants are referred to herein, collectively, as the “Warrants.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 5th, 2024 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 5, 2024, between Adverum Biotechnologies, Inc., a Delaware corporation (the “Company”), and the several purchasers identified on the signature pages hereto (each, including its respective successors and assigns, a “Purchaser”).
